Tue, March 29, 2016
Mon, March 28, 2016
Thu, March 24, 2016
Wed, March 23, 2016
Tue, March 22, 2016
Mon, March 21, 2016
Fri, March 18, 2016
Thu, March 17, 2016

Kennen MacKay Maintained (BMRN) at Buy with Decreased Target to $109 on, Mar 22nd, 2016

Kennen MacKay of Credit Suisse, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $114 to $109 on, Mar 22nd, 2016.

Kennen has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Kennen's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Kennen


  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $105 on, Friday, February 26th, 2016
  • Joseph Schwartz of "Leerink Swann" Maintained at Buy with Decreased Target to $120 on, Tuesday, February 23rd, 2016